NEW YORK (GenomeWeb News) – CombiMatrix said today that the 2007 Defense Appropriations Bill, recently signed into law, includes two new allocations of $1 million each for the company’s development of microarray technologies for the detection of biological threat agents and infectious pathogens.

According to the company, one of the allocations was specifically granted to address concern over the Eurasian Avian Influenza A Virus, also known as H5N1.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.